The UK’s railway pension scheme RPMI Railpen was recently involved in the latest round of funding for Oxford Nanopore Technologies, a biotechnology firm specialising in gene-technology. Funds Europe takes a deeper look at Oxford Nanopore to learn more about the company and the role of private equity in biotechnology. -